Showing 981-990 of 10608 results for "".
Surgery Not Required?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/surgery-not-required/19723/Patients increasingly want non-surgical options for skin tightening. Fortunately, a plethora of highly effective options exist, from ultrasound to radiofrequency, according to Mitchel Goldman, MD.The Science Driving Topicals Into the Future
https://practicaldermatology.com/topics/psoriasis/the-science-driving-topicals-into-the-future/19721/On the therapeutic front, one topic Neal Bhatia, MD is paying particularly close attention to is recent advances in vehicle science, which offer novel and intriguing strategies to improve delivery of topical applications to and through the skin.What Are You Looking Forward to at SDDS?
https://practicaldermatology.com/topics/practice-management/what-are-you-looking-forward-to-at-sdds/19717/Sarah Lonowski, MD, MBA, Division of Dermatology, University of California Los Angeles, Los Angeles talks about what she hopes to learn at the inaugural SDDS in May. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterContinental San Diego: sddeDermWireTV: Skin Cancer Foundation’s Big See, Cosmetic Consumer Insights, Cosmetic Bootcamp Recap
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-foundation-confronts-the-big-see-cosmetic-consumer-insights/19632/The Skin Cancer Foundation’s new multiyear public service campaign, “The Big See," urges proactive approaches to skin cancer diagnosis. Results of the Synchrony Financial Cosmetic Path to Purchase Research Study show that 8 in 10 cosmetic consumers said they researched a procedure or treatment befoSCALE 2019: Meeting Highlights from Music City
https://practicaldermatology.com/topics/practice-management/scale-2019-meeting-highlights-from-music-city/19619/With an emphasis on both medical and cosmetic dermatology as well as practice management, Music City Scale or the Symposium for Cosmetic Advances and Laser Education has something for everyone, organizers says. Co-chairs Michael Gold, MD and Brian Biesman, MD are joined by several presenters to discUpdates from Principia, Sebacia, and Candela
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranPopup Subscription Forms: Could They be Costing you Potential Patients?
https://practicaldermatology.com/topics/practice-management/popup/18364/If you are using popup subscription forms to build your email list, you could be losing potential patients while you gain subscribers. Watch this video from Ekwa.com to learn how to avoid common mistakes and build a strong mailing list the right way.Cash Savings Alternative: Increase Returns & Maintain Liquidity
https://practicaldermatology.com/topics/practice-management/cash-savings-alternative-increase-returns-maintain-liquidity--wnhimepo/18366/OJM Group Director of Financial Advisors Michael Lewellen, CFP provides an overview and financial example of a cash savings alternative that offers 100% liquidity while providing a higher return than traditional investment vehicles. Click here to request or download a free copy of Wealth ProtectionLaser Options for Scars
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-options-for-scars/18814/Advances in laser technology—particularly fractional lasers—offer an effective option for diminishing the appearance of scars, says Jill Waibel, MD. She offers a review of how she's treating all types of scars and skin types, and discusses how and why keloids have been reclassified as a disease.Drug Prices Soar, Amgen Files BLA for Biosimilar to Humira
https://practicaldermatology.com/topics/practice-management/dermwiretv-drug-prices-soar-amgen-files-bla-for-biosimilar-to-humira/18672/In this edition, Amgen Submits ABP 501—first Adalimumab biosimilar; prices for dermatology drugs jump and a survey explores patient knowledge of antibiotic resistance. Also, Almirall acquires Veltin from Sitefel/GSK.